Kai‐Lung Tsai
Kai‐Lung Tsai publishes mostly in Surgery, Oncology and Hepatology, on topics such as Colorectal Cancer Surgical Treatments, Helicobacter pylori-related gastroenterology studies and Gastrointestinal disorders and treatments.
- World rank
- #5,227,040 of 7,710,434 ranked researchers
- Rank in Taiwan
- #40,067 of 57,035
- Works
- 21
- Citations
- 283
- Citations per work
- 13.5
What does Kai‐Lung Tsai research?
Kai‐Lung Tsai's work is mostly in Medicine (76%), Computer Science (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1676.3%
- Medicine1676.3%
- Everything else420.3%
- Physical Sciences13.4%
- Computer Science13.4%
- 1Surgery39% of their works
- 2Oncology17% of their works
- 3Hepatology8% of their works
- 4Epidemiology7% of their works
- 5Pulmonary and Respiratory Medicine5% of their works
- 6Computer Vision and Pattern Recognition3% of their works
Research topics
- Colorectal Cancer Surgical Treatments
- Helicobacter pylori-related gastroenterology studies
- Gastrointestinal disorders and treatments
- Gastrointestinal Tumor Research and Treatment
- Hepatocellular Carcinoma Treatment and Prognosis
- Colorectal Cancer Treatments and Studies
- Inflammatory Biomarkers in Disease Prognosis
- Ferroptosis and cancer prognosis
Which keywords describe Kai‐Lung Tsai's research?
The keywords of their largest research topics: Clinical Practice Guidelines, Diagnosis, Inflammation, Treatment, Cancer, Tumor Microenvironment, Gastric Cancer and Helicobacter pylori.
- Sunitinib
- Liver Cancer
- Immunity
- Hepatocellular Carcinoma
- Cetuximab
- Rectal Cancer
- Meckel's Diverticulum
- Helicobacter pylori
- Tumor Microenvironment
- Treatment
- Diagnosis
- Clinical Practice Guidelines
- Inflammation
- Cancer
- Gastric Cancer
- Intussusception
- Preoperative Chemoradiotherapy
- Cell Death
- Ferroptosis
- Imatinib Mesylate
- KRAS Mutations
- Neutrophil-to-Lymphocyte Ratio
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 22 words, with their numbers
- Clinical Practice Guidelines52 topics
- Diagnosis52 topics
- Inflammation52 topics
- Treatment52 topics
- Cancer42 topics
- Tumor Microenvironment42 topics
- Gastric Cancer31 topic
- Helicobacter pylori31 topic
- Intussusception31 topic
- Meckel's Diverticulum31 topic
- Preoperative Chemoradiotherapy31 topic
- Rectal Cancer31 topic
- Cell Death21 topic
- Cetuximab21 topic
- Ferroptosis21 topic
- Hepatocellular Carcinoma21 topic
- Imatinib Mesylate21 topic
- Immunity21 topic
- KRAS Mutations21 topic
- Liver Cancer21 topic
- Neutrophil-to-Lymphocyte Ratio21 topic
- Sunitinib21 topic
Where does Kai‐Lung Tsai work?
Kai‐Lung Tsai's main affiliation in the publication record is Chang Gung University, Taiwan.
How many publications and citations does Kai‐Lung Tsai have?
OpenAlex counts 21 works and 283 citations for Kai‐Lung Tsai, an h-index of 8, ranking #5,227,040 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Kai‐Lung Tsai. Posts are plain text and can be reported.